Skip to main content
Caplight Logo









AiViva BioPharma

AiViva BioPharma

Private
Costa Mesa, CaliforniaHealthcare & Life Scienceshttps://aiviva.com/

Last Round

Crowdfunding

Dec 14, 2022

Est. Valuation

$49.79M

Total Funding Raised

$31.03M

Company Overview

AiViva BioPharma is a biotechnology company that develops novel pharmaceutical products and focal therapies for dermatology, ophthalmology, oncology, and urology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

drug delivery platformJEL technologyfocal therapyprolonged release drugdrug reformulationclinical stage biotechlocalized drug deliveryinjectable hydrogelophthalmologydermatologyinjectable depotthermoresponsive hydrogeloncologywet AMDnonmelanoma skin cancer505(b)(2) pathwayurology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AiViva BioPharma Comparables

Compare AiViva BioPharma with similar companies based on industry and business-model similarity.

AiViva BioPharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AmacaThera
76%
Ripple Therapeutics
76%
Re-Vana Therapeutics
73%

AiViva BioPharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingDec 14, 2022
Series AFeb 1, 2022

Key People

Founding team and executive leadership

Diane Tang-Liu

Co-Founder, CEO & President

Founding Team

AiViva BioPharma Investors

Notable investors and investment history

AiViva BioPharma investors
InvestorRounds
StartEngine CrowdfundingCrowdfunding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2026

    Monthly visitors increased 202% MoM.

  • Nov 9, 2024

    Monthly visitors increased 83% MoM, reaching 1.7K.

AiViva BioPharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AiViva BioPharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AiViva BioPharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersCosta Mesa, California
Employee Range18
Year Founded2015
Last FundingDec 14, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?